scholarly journals Research and Implementation of Mobile Advertising System Based on Location Service

Author(s):  
Prof. Ankita Karale

A Location Based Mobile Advertising is an information and entertainment service, accessible through Smartphones through the ability to use the location of mobile phones. Marketers should be allowed to publish and classify ads according to the consumer interests. If information is not available voluntarily in the short term, Then the consumers Interest may be lost in order to purchase the products. They need to find more information and location without having to make a lot of effort. The Location-Based Mobile Advertising service allows customers to receive advertiser details such as their Location, discounts, and product descriptions. This service also provides information about the nearest tourist destinations according to their location.

MANASA ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 98-106
Author(s):  
Medwin Wisnu Prabowo

There are many crimes that happened in this era, which one of them is corruption. Corruption has become a major phenomenon for each country in this world. Even more, it is not only male who doing the corruption, but female also. They were get some money to satisfy themselves although they have to break the law. This phenomenon has attracted researcher to study the female inmates who was doing corruption, and its relation to psychopathic symptom. Three female inmates in Sukamiskin Penitentiary Institute Class IIA – Bandung, who were convicted based on corruption cases, were chosen as subjects of this study. The result showed that all of three female inmates have a tendency to become a Psychopath, but in the low level to middle level tendencies. The three dominant Psychopathic Symptoms that found: pathological lying, lack of remorse or guilt, and short-term marital relationships. It can be summarized and recommended that among 3 subjects need to receive a counseling and/or psychoeducation so they will be more honest in their work setting, and to educate them that its important to have a good relationship to build a harmonious family.


2020 ◽  
Vol 148 ◽  
Author(s):  
Pingzheng Mo ◽  
Liping Deng ◽  
Xiaoping Liu ◽  
Shicheng Gao ◽  
Ke Liang ◽  
...  

Abstract The epidemic of coronavirus disease 2019 (COVID-19) began in China and had spread rapidly to many other countries. This study aimed to identify risk factors associated with delayed negative conversion of SARS-CoV-2 in COVID-19 patients. In this retrospective single-centre study, we included 169 consecutive patients with confirmed COVID-19 in Zhongnan Hospital of Wuhan University from 15th January to 2nd March. The cases were divided into two groups according to the median time of SARS-CoV-2 negative conversion. The differences between groups were compared. In total, 169 patients had a median virus negative conversion time of 18 days (interquartile range: 11–25) from symptom onset. Compared with the patients with short-term negative conversion, those with long-term conversion had an older age, higher incidence of comorbidities, chief complaints of cough and chest distress/breath shortness and severer illness on admission, higher level of leucocytes, neutrophils, aspartate aminotransferase, creatine kinase and erythrocyte sedimentation rate (ESR), lower level of CD3+CD4+ lymphocytes and albumin and more likely to receive mechanical ventilation. In multivariate analysis, cough, leucocytes, neutrophils and ESR were positively correlated with delayed virus negative conversion, and CD3+CD4+ lymphocytes were negatively correlated. The integrated indicator of leucocytes, neutrophils and CD3+CD4+ lymphocytes showed a good performance in predicting the negative conversion within 2 weeks (area under ROC curve (AUC) = 0.815), 3 weeks (AUC = 0.804), 4 weeks (AUC = 0.812) and 5 weeks (AUC = 0.786). In conclusion, longer quarantine periods might be more justified for COVID-19 patients with cough, higher levels of leucocytes, neutrophils and ESR and lower levels of CD3+CD4+ lymphocytes.


2008 ◽  
Vol 22 (8) ◽  
pp. 1113-1125 ◽  
Author(s):  
Caterina Cinel ◽  
Angela Boldini ◽  
Elaine Fox ◽  
Riccardo Russo

2005 ◽  
Vol 39 (5) ◽  
pp. 840-842 ◽  
Author(s):  
Michael J Kovacs ◽  
Clive Kearon ◽  
Jim A Julian ◽  
James D Douketis ◽  
Christine Demers ◽  
...  

BACKGROUND: Some patients develop fatigue while taking warfarin, but causality is uncertain. OBJECTIVE: To assess whether warfarin use is associated with fatigue. METHODS: This investigation was a substudy of a randomized double-blind trial in 13 outpatient thromboembolism clinics. Subjects who had received one month of open-label warfarin therapy for venous thromboembolism due to a transient risk factor were randomly assigned to receive warfarin or placebo for 2 months and followed for another 9 months after stopping the study drug. Fatigue was measured using a Likert scale, and change of fatigue was measured by the patient's global rating. RESULTS: In 87 subjects, the overall ratings of fatigue were 0.1 unit lower (95% CI 0.6 units lower to 0.4 units higher) while taking warfarin. Global rating for change in fatigue intensity showed no increase of fatigue with warfarin use. CONCLUSIONS: The short-term use of warfarin was not associated with symptoms of fatigue.


Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 578-578 ◽  
Author(s):  
Lynn Boshkov ◽  
Grace Chien ◽  
Donna VanWinkle ◽  
Antony P. Furnary ◽  
Yingxing Wu ◽  
...  

Abstract Introduction: Red cell (RBC) transfusion (vs no transfusion) in cardiac surgery is associated with higer operative mortality and shortened long-term survival. Studies have suggested use of leukoreduced RBCs vs standard RBCs in transfused cardiac surgery patients is associated with improved short term (60 day) survival. It is unclear if this benefit persists longer term. Study Aim: This prospective, randomized, double-blind, 3-center trial compared short term and intermediate-term mortality (2–12 mos) in adult cardiac surgery patients undergoing cardiopulmonary bypass (CPB) randomized to receive either prestorage leukoreduced RBCs (LR-RBCs) vs standard RBCs (S-RBCs) Methods: 1226 cardiac surgery patients (undergoing coronary artery bypass grafting, cardiac valve replacement, or a combination of the two) were pre-operatively randomized to receive either LR- or S-RBCs. Patients were operated on by the same group of surgeons. Patients and clinicians were blinded as to product type. All deaths were verified by National Death Index records. Results: 562 patients (45.8%) were transfused: 304 received LR-RBCs and 258 S-RBCs. Groups were statistically equivalent demographically and by all Society of Thoracic Surgery risk criteria. Operative mortality was not affected. However a survival benefit for the LR-RBC group was evident at 60 days which persisted for 12 months (see Table 1). Mortality for non-transfused patients was significantly lower than for patients receiving either LR- or S-RBCs at all time points (p<0.0001). Conclusion: In adult cardiac surgery patients undergoing CPB who require transfusion, use of LR-RBCs vs S-RBCs is associated with significant improvement in survival at 2 months, and this survival advantage persists for up to 1 year. Table 1: Percent (%) Mortality--Operative (Op) and Cumulative by Month (mo) Post-operative Op 2 mo 4 mo 6 mo* 9 mo* 12 mo* *Kaplan-Meier (KM) analysis LD-RBCs 4.9 4.9 5.3 5.9 5.9 7.0 S-RBCs 7.0 9.7 9.7 10.1 11.3 11.7 p-value 0.305 0.029 0.044 0.070 0.025 0.053


Sign in / Sign up

Export Citation Format

Share Document